TP53 and ovarian neoplasm: All the discrepancies between reports may be explained by differences in the techniques used for the analysis of TP53 status, patient sample size, biological and/or histological ovarian tumor subset analyses, different treatments of the patient population, different (modern) prognostic covariates used in the multivariate analyses, the inherent subjectivity in certain approaches, and publication bias.